Show simple item record

dc.contributor.authorPetheram, K
dc.contributor.authorDobson, R
dc.date.accessioned2024-07-05T08:13:21Z
dc.date.available2024-07-05T08:13:21Z
dc.date.issued2024-06-22
dc.identifier.citationPetheram K, Dobson R. All women with multiple sclerosis should start hormone replacement therapy at menopause unless contraindicated: Commentary. Multiple Sclerosis Journal. 2024;0(0). doi:10.1177/13524585241254989en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/97859
dc.format.extent13524585241254989 - ?
dc.languageeng
dc.publisherSAGE Publicationsen_US
dc.relation.ispartofMult Scler
dc.rightsThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
dc.titleAll women with multiple sclerosis should start hormone replacement therapy at menopause unless contraindicated: Commentary.en_US
dc.typeArticleen_US
dc.rights.holder© The Author(s), 2024.
dc.identifier.doi10.1177/13524585241254989
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/38907631en_US
pubs.notesNot knownen_US
pubs.publication-statusPublished onlineen_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record